Clinical Trial Update: Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of HRS9531 in adults with Type 2 diabetes mellitus treated with basal insulin, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: RECRUITING